Frontiers in Immunology (Apr 2024)

The role of ESAT-6 in tuberculosis immunopathology

  • Beatriz B. S. Passos,
  • Beatriz B. S. Passos,
  • Beatriz B. S. Passos,
  • Mariana Araújo-Pereira,
  • Mariana Araújo-Pereira,
  • Mariana Araújo-Pereira,
  • Caian L. Vinhaes,
  • Caian L. Vinhaes,
  • Caian L. Vinhaes,
  • Caian L. Vinhaes,
  • Caian L. Vinhaes,
  • Eduardo P. Amaral,
  • Bruno B. Andrade,
  • Bruno B. Andrade,
  • Bruno B. Andrade,
  • Bruno B. Andrade,
  • Bruno B. Andrade

DOI
https://doi.org/10.3389/fimmu.2024.1383098
Journal volume & issue
Vol. 15

Abstract

Read online

Despite major global efforts to eliminate tuberculosis, which is caused by Mycobacterium tuberculosis (Mtb), this disease remains as a major plague of humanity. Several factors associated with the host and Mtb interaction favor the infection establishment and/or determine disease progression. The Early Secreted Antigenic Target 6 kDa (ESAT-6) is one of the most important and well-studied mycobacterial virulence factors. This molecule has been described to play an important role in the development of tuberculosis-associated pathology by subverting crucial components of the host immune responses. This review highlights the main effector mechanisms by which ESAT-6 modulates the immune system, directly impacting cell fate and disease progression.

Keywords